Related Experiment Video

Updated: Jun 8, 2025

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence
08:07

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence

Published on: April 28, 2023

1.4K

AP3M2: A key regulator from the nervous system modulates autophagy in colorectal cancer

Maguie El Boustani1, Nayla Mouawad2, Monah Abou Alezz3

  • 1Nephrology and Dialysis Unit, Genomics of Renal Diseases and Hypertension Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Tissue & Cell
|November 3, 2024
PubMed

Insights

Targeting the AP3M2 gene, crucial in protein trafficking, shows promise for colorectal cancer (CRC) treatment. Inhibiting AP3M2 reduces CRC cell viability by influencing autophagy and reactive oxygen species (ROS).

Area of Science:

  • Molecular oncology
  • Cancer genomics
  • Cellular biology

Background:

  • Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide.
  • Molecular profiling, like that from The Cancer Genome Atlas, is vital for identifying therapeutic targets in CRC subtypes.
  • The AP3M2 gene's role in CRC is largely unexplored, despite its known function in protein trafficking.

Purpose of the Study:

  • To investigate the potential of the AP3M2 gene as a therapeutic target in colorectal cancer.
  • To elucidate the functional significance of AP3M2 in CRC cell lines.
  • To explore the relationship between AP3M2 expression, autophagy, and reactive oxygen species (ROS) in CRC.

Main Methods:

  • Utilized RNA interference (RNAi) to inactivate the AP3M2 gene in CRC cell lines.
  • Assessed the impact of AP3M2 knockdown on cell viability in HCT-116, CACO2, and HT29 cell lines.
  • Analyzed the correlation between AP3M2 expression, autophagy-related genes, and ROS levels.

Main Results:

  • AP3M2 was found to be amplified in colorectal cancer cell lines.
  • Knockdown of AP3M2 significantly decreased the viability of multiple CRC cell lines.
  • AP3M2 expression correlated with changes in autophagy-related gene expression and ROS levels.

Conclusions:

  • AP3M2 acts as a potential oncogene in colorectal cancer.
  • Targeting AP3M2 may offer a novel therapeutic strategy for CRC.
  • The autophagy-ROS pathway is implicated in the mechanism by which AP3M2 influences CRC progression.
Keywords:
AP3M2AutophagyColon cancerOncogeneROS

More Related Videos

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

760
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

416

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K